Enterprise Ireland has undertaken an extensive study in the Human Pharma space across four markets; France/Belgium/UK/Switzerland.
The findings form the basis of our webinar ‘Opportunites in Human Pharma’ which provides an overview of the sector with key insights from industry experts on the the latest trends and opportunities to help inform Irish companies looking to grow in this space.
Chaired by Deirdre Glenn, Enterprise Ireland’s head of life sciences with insights from:
• Suzanne Coles, CEO & Founder of Tech Novia Solutions
Today, @ElkstonePartner has launched a new €100m fund for high-potential Irish start-ups in the seed and pre-Series A stages. Enterprise Ireland is one of the backers of the fund, providing €20m from its seed and venture capital scheme. https://rebrand.ly/wislesy #GlobalAmbition